Navigation Links
Dyadic International Engages The Abraham Group as Strategic Advisor
Date:6/21/2010

JUPITER, Fla., June 21 /PRNewswire-FirstCall/ -- Dyadic International, Inc. (Pink Sheets: DYAI), a global biotechnology company whose cutting-edge C1 platform technology addresses the needs of the multi-billion dollar biofuels market by producing enzymes at industrial scale which efficiently convert biomass into ethanol and other forms of alternative energy, announced today that it has engaged the influential consulting firm, The Abraham Group, to provide strategic advice and transactional assistance to Dyadic, as its exclusive biofuels client, as it actively pursues licensing opportunities and other strategic collaborations throughout the world. The Abraham Group is led by former U.S. Energy Secretary Spencer Abraham, who will also serve as a senior advisor to Dyadic.

(Logo: http://photos.prnewswire.com/prnh/20091214/DYADICLOGO )

(Logo: http://www.newscom.com/cgi-bin/prnh/20091214/DYADICLOGO )

Dyadic's Executive Director of Strategic Alliances, Anne Whitehead, stated, "We are very pleased that Secretary Abraham and his firm have selected Dyadic as its exclusive biofuels client. The Abraham Group will help Dyadic build upon its previous licensing successes and enhance its biofuels strategy by leading an international initiative to further communicate the advantages of Dyadic’s C1 platform technology and its R&D capabilities to major international energy groups that are committed to the efficient and rapid commercialization of cellulosic ethanol and other forms of sustainable energy."

Secretary Abraham stated, "The future of United States energy policy will be based on our country's ability to develop and implement many different types of technologies to meet our growing energy needs. We are excited to work with Dyadic whose technology has already been licensed and shown to be a key component in the process of developing and commercializing non-food biofuels and other applications worldwide."

Dyadic's President and CEO, Mark Emalfarb, added, "We are excited to have a firm of the caliber of The Abraham Group represent Dyadic. Secretary Abraham's commitment to Dyadic is a clear sign of the progress and innovations we are achieving in the area of bioenergy and lends further credibility to our company and its technologies. We expect The Abraham Group's expertise and relationships in the global energy sector will help accelerate the further development and monetization of our technologies through new licensees and other collaborations."

Dyadic believes that its proprietary and patented C1 platform technology can be used as a cost-effective method to develop and produce alternatives to oil and petroleum-based products for a variety of multi-billion dollar markets. The C1 platform technology is based on a genetically sequenced fungal microorganism that has been genomically annotated by Scripps Florida, a division of The Scripps Research Institute. As a result of more than a decade of continued research and development, the C1 platform can be readily programmed to develop and produce novel enzymes on a commercial scale at low cost under broad operating conditions. These unique enzymes provide increased flexibility in the processing of multiple forms of biomass by biorefineries into fermentable sugars which, in turn, can be converted into biofuels such as cellulosic ethanol and butanol as well as chemicals, polymers and plastics.

Dyadic has previously licensed its C1 platform technology in the area of biofuels on a non-exclusive basis to Spanish biofuels and energy producer Abengoa Bioenergy, as well as to Codexis, a biofuels partner of Royal Dutch Shell. Dyadic and these licensees are continuing to improve the C1 platform technology to make manufacturing processes more efficient in producing greater quantities of biofuels at lower costs.

About The Abraham Group

The Abraham Group is a Washington, D.C. based international strategic consulting firm that specializes in assisting clients seeking opportunities in the international energy sector. The firm's Chairman & CEO, Spencer Abraham, served as U.S. Secretary of Energy from 2001 to 2005 and as a U.S. Senator from 1995 to 2001. The firm's partners include Joseph McMonigle, who was former Chief of Staff at the U.S. Department of Energy and Vice Chairman of the International Energy Agency Board of Governors, and Majida Mourad, who served as Senior Advisor to the Secretary as a lead Department representative on international energy matters in the Middle East, Australia, and Russia as well as various European and Asian countries. Please visit The Abraham Group's website at www.abrahamgroupllc.com.

About Dyadic

Dyadic is a global biotechnology company that uses its patented and proprietary technologies for the discovery, development, manufacture and sale of enzyme products and solutions to address the needs of the bioenergy, biopharmaceutical and industrial enzyme markets. Please visit Dyadic's website at www.dyadic.com.

Cautionary Statement for Forward-Looking Statements

Certain statements contained in this press release are forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause Dyadic's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Except as required by law, Dyadic expressly disclaims any intent or obligation to update any forward-looking statements.


'/>"/>
SOURCE Dyadic International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Dyadic International to Present at Rodman & Renshaw 6th Annual Global Healthcare Conference
2. Dyadic International Strengthens Management Team
3. Dyadic International Extends Collaboration With The Scripps Research Institute
4. Tengion Presents New Data Supporting its Organ Regeneration Platform™ at 8th Annual Meeting of the International Society for Stem Cell Research
5. Very Small Embryonic-Like Stem Cell Mobilization Data Presented at International Society for Stem Cell Research Annual Meeting
6. PRA International Opens Phase I Unit in Budapest
7. Hamilton Thorne to launch Staccato(TM) laser at International Society of Stem Cell Research Annual Meeting
8. PRA International Exhibits at European Hematology Association Congress
9. Prestigious International Champalimaud Vision Award to US Scientists
10. Yongye International Hosts Official NASDAQ Visit to Inner Mongolia
11. Tengion Presents New Data Supporting Key Urologic and Kidney Programs at 16th Annual Meeting of the International Society for Cellular Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, a division ... tuned and optimized exclusively for Okuma CNC machining centers at The International Manufacturing ... collaboration among several companies with expertise in toolholding, cutting tools, machining dynamics and ...
(Date:6/23/2016)... , June 23, 2016 ... research report to its pharmaceuticals section with historic ... details and much more. Complete report ... 151 pages, profiling 15 companies and supported with ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global ...
(Date:6/22/2016)... , June 22, 2016 Research and ... Global Markets" report to their offering. ... billion in 2014 from $29.3 billion in 2013. The market is ... of 13.8% from 2015 to 2020, increasing from $50.6 billion in ... projected product forecasts during the forecast period (2015 to 2020) are ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/15/2016)... , April 15, 2016  A new ... make more accurate underwriting decisions in a fraction ... timely, competitively priced and high-value life insurance policies ... screenings. With Force Diagnostics, rapid testing ... lifestyle data readings (blood pressure, weight, pulse, BMI, ...
Breaking Biology News(10 mins):